Progress in Rare Cancers | Cancer Today
With the rise of patient-driven registries, scientists are making advances in rare cancer research and treatment.
With the rise of patient-driven registries, scientists are making advances in rare cancer research and treatment.
It is my sincere and express wish that any and all remuneration, actual or potential, that may be my due, be instead directed towards all…
FDA-AACR Workshop: How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases Date: May 9, 2024 | 9:00 a.m. – 4:00 p.m. Location:…
PURPOSE Nodular lymphocyte–predominant Hodgkin lymphoma (NLPHL) is a rare cancer, and large international cooperative efforts are needed to evaluate the significance of clinical risk factors…
Overview The 12th Annual Symposium on Global Cancer Research (ASGCR) will be held virtually May 6 – May 9, 2024 [8AM-12PM Eastern Time each day]. See…
AACR CEO Margaret Foti, PhD, MD (hc) (back left), with cancer survivor Cayden Addison (front left), his brother Christian (front right), and his mother Courtney…
This cohort study assesses treatment patterns and attrition rates in patients with advanced urothelial carcinoma in US oncology clinics.
This cohort study assesses treatment patterns and attrition rates in patients with advanced urothelial carcinoma in US oncology clinics.
June 27-29 (EDT), June 28-30 (JST), 2024Kyoto Tokyu HotelKyoto, Japan On-Demand: On-demand streaming will be available until September 30, 23:59 (JST). Conference Chairs Luis A.…
Background: Despite advances in the treatment of early triple-negative breast cancer (TNBC), patients with residual invasive disease after neoadjuvant therapy h…
As empresas AstraZeneca e Daiichi-Sankyo anunciaram à imprensa que o estudo de fase 3, randomizado, Destiny-Breast 06 apresentou resultados positivos para o seu desfecho primário.…